PolyethyleneGlycol3350 Laxative vs Placebo in Constipated Children
Completed · Phase 4
Conditions studied: Constipation
In brief
Assess the safety and efficacy of polyethyleneglycol3350 laxative as compared to placebo therapy in pediatric patients with a history of constipation.
Key facts
- Study ID
- NCT00153114
- Run by
- Braintree Laboratories
- People needed
- 100
- Starts
- 2003-01-01
- Last updated by the study team
- 2013-02-07
Who can join
Age: 4 and older, up to 16. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female outpatients between the ages of 4 to 16 years.
- Adolescent female patients must not be pregnant or lactating.
- constipated according to ROME I definition
- Two or fewer bowel movements during the initial observation week.
- Absence of a stool impaction
- Bowel movement after receiving enema
- Are otherwise in good health, as judged by a physical examination.
- Parent or guardian is mentally competent to sign an instrument of informed consent
You may not qualify if…
- Patients with heme positive stool at baseline exam.
- Patients with fecal impaction at baseline, or after the observation period, as indicated by physical exam
- Patients with known or suspected perforation or obstruction other than fecal impaction.
- Patients who are breastfeeding, pregnant or intend to become pregnant during the study.
- Female patients of childbearing potential who refuse a pregnancy test.
- Patients with a known history of organic cause for their constipation.
- Patients with congenital malformations that produce constipation (Hirschsprung's disease, imperforate anus, children with cerebral palsy or other neurologic abnormalities, or systemic diseases).
- History of gastric retention, inflammatory bowel disease, bowel resection, or colostomy.
- Use of concomitant medications that cause constipation
- Patients who, in the opinion of the investigator, should not be included in the study for any reason, including inability to follow study procedures.
- Patients with known allergy to polyethyleneglycol or polyethyleneglycol containing medications.
- Patients with clinically significant elevations of TSH or abnormal plasma electrolytes.
- Patients who, within the past 30 days have participated in an investigational clinical study
Where it is running
- Study site — Boston, Massachusetts, United States
- Study site — Morristown, New Jersey, United States
- Study site — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.